Fig. 1From: Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitusStudy design. Asterisk accepted when the difference between daily doses of each insulin product and total insulin products were ±10 % of those on the first day of treatmentBack to article page